![]() | This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
Rikard Holmdahl is a Swedish physician and immunologist. He was appointed as a full professor and the head of Medical Inflammation Research (MIR) unit at Lund University in 1993. In 2008, Rikard and his whole research group were moved to Karolinska Institute. [1] His team was the first to discover and positionally clone a single nucleotide polymorphism at the Ncf1 gene causing susceptibility to autoimmune diseases such as Rheumatoid Arthritis in rat models. [2] Rikard is an adjunct member of the Nobel Committee for physiology or medicine between 2016-2021 [3] and was ranked 3rd among the top immunology scientists in Sweden in 2024. [4]
Rikard Holmdahl obtained his Doctor of Philosophy and Medical Doctor degrees at Uppsala University in 1985 and 1987, respectively. [5] [1] After his clinical residency training during 1988–1989, he started his research fellowship and was promoted as Associate Professor at Swedish Medical Research Council in 1990. [1]
He became a full professor since 1993, and he is now the head of the MIR unit at Division of Immunology at Karolinska Institute (2008–present). [6] He is also serving as visiting professor at Department of Medical Biochemistry and Microbiology, at Uppsala University since March 2025. [7]
He was a member of the Nobel Assembly during 2014–2021 and an adjunct member of the Nobel committee for physiology or medicine during 2016–2021. [3] He is also a member of the Royal Swedish Academy of Science since 2017. [8]
{{cite journal}}
: Cite journal requires |journal=
(help)